Frontlight ResearchEarly access
Trial site
Torbay and South Devon NHS Foundation Trust
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- ANCA-associated vasculitis1 trial
- Familial hypercholesterolaemia1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Idiopathic pulmonary fibrosis1 trial
- Immune thrombocytopenia (ITP)1 trial
- Kidney cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Rheumatoid arthritis1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Taiho Oncology, Inc.2 trials
- BioNTech SE1 trial
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1 trial
- Guy's and St Thomas' NHS Foundation Trust1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Recruiting
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Active, not recruiting
Recruiting
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
Recruiting
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
Recruiting
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Kidney cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026